...
首页> 外文期刊>Clinical and Translational Allergy >Effectiveness of premedication for hypersensitivity reactions to radiocontrast media in one tertiary hospital
【24h】

Effectiveness of premedication for hypersensitivity reactions to radiocontrast media in one tertiary hospital

机译:一家三级医院对放射性造影剂超敏反应的前药治疗有效性

获取原文
           

摘要

IntroductionFor patients with a known history of hypersensitivityreactions to radiocontrast media (RCM), premedicationwith antihistamines and corticosteroids before receivingRCM is recommended. It has been shown that such premedicationdecreases the frequency of mild and aggregateallergic like reactions. However, premedication doesnot prevent all subsequent reactions.ObjectivesWe investigate the effectiveness of premedication forhypersensitivity reactions to radiocontrast media (RCM)in one tertiary hospital.MethodsWe reviewed electronic medical records of all thepatients who had been prescribed premedication withsystemic steroid or antihistamine for hypersensitivityreactions to RCM from January 2009 to January 2012 inSeoul National University Hospital. Data of previoushypersensitivity reactions and reactions after re-exposureto RCM with premedication was extracted.ResultsA total of 401 patients with a history of hypersensitivityreaction to RCM and were premedicated at re-exposureto RCM. Male was 177 (44.1%) and mean age was55.83??11.92 years. Most common hypersensitivity symptomwas urticaria (259, 64.6%), followed by itching(36.7%), rash (21.4%) and angioedema (13.2%). Hypotensionwas reported in 9 (2.2%) and syncope 5 (1.2%). Systemicsteroid was prescribed in 143 patients (35.4%).After premedication, 139 patients (77.7%) had no hypersensitivityreactions to re-exposed RCM. Incidence ofsymptom after premedication such as uriticaria (12.4%),itching (5.6%), rash (5.1%), angioedema (2.2%) were significantlydecreased compared with previous incidence(P0.05)ConclusionThe use of corticosteroid or antihistamine beforeadministration of RCM may diminish the overall prevalenceof reactions. Randomized controlled studies of theeffects of pretreatment in patients with hypersensitivityreaction to RCM were needed.
机译:简介对于已知对放射性造影剂(RCM)有超敏反应史的患者,建议在接受RCM之前先进行抗组胺药和皮质类固醇的预防性用药。业已表明,这种用药减少了轻度和聚集性过敏反应的频率。然而,预防性用药并不能阻止所有随后的反应。目的我们研究在一间三级医院中预防性用药对放射性对比剂(RCM)的超敏反应的有效性。 2009年1月至2012年1月在首尔国立大学医院。提取以前的超敏反应数据和再用RCM进行预用药后的反应。结果共有401例对RCM有超敏反应史的患者,并在再用RCM进行过用药。男性为177(44.1%),平均年龄为55.83 ?? 11.92岁。最常见的超敏症状是荨麻疹(259,64.6%),其次是瘙痒(36.7%),皮疹(21.4%)和血管性水肿(13.2%)。低血压的发生率为9(2.2%)和晕厥5(1.2%)。 143例患者(35.4%)开出了全身性类固醇激素处方药,139例患者(77.7%)对再暴露的RCM没有过敏反应。与以前的发病率相比,服药后出现的症状如荨麻疹(12.4%),瘙痒(5.6%),皮疹(5.1%),血管性水肿(2.2%)的发生率显着降低。减少反应的总体患病率。需要对RCM过敏反应患者进行预处理效果的随机对照研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号